kindolor tosylate
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 21, 2024 (NCT06243835)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
SCN10A modulator
SCN9A modulator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06243835 | Phase 1 | Apr 21, 2024 | Lohocla Research Corporation, National Institute on Drug Abuse (NIDA), University of California, San Diego |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lohocla Research Corporation | For profit | 1 | 1 | 1 | 2024 |
| National Institute on Drug Abuse (NIDA) | Government | 1 | 0 | 1 | 2024 |
| University of California, San Diego | Academic/Hospital | 1 | 0 | 1 | 2024 |
3 organizations
Page 1 / 1